ARTICLE | Company News
AOP Orphan, Cardiome deal
May 18, 2015 7:00 AM UTC
AOP Orphan granted Cardiome rights to market IV and powder formulations of Esmocard esmolol in Italy, France, Spain and Belgium. The small molecule adrenergic receptor beta 1 ( ADRB1) antagonist is ...